Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;173(4):560-72.
doi: 10.1111/bjh.13958. Epub 2016 Feb 23.

Anaplastic large cell lymphoma in paediatric and young adult patients

Affiliations
Review

Anaplastic large cell lymphoma in paediatric and young adult patients

Suzanne D Turner et al. Br J Haematol. 2016 May.

Abstract

Anaplastic large cell lymphoma (ALCL) is a heterogeneous disease of debateable origin that, in children, is largely anaplastic lymphoma kinase (ALK) positive with aberrant ALK activity induced following the formation of chromosomal translocations. Whilst the survival rates for this disease are relatively high, a significant proportion (20-40%) of patients suffer disease relapse, in some cases on multiple occasions and therefore suffer the toxic side-effects of combination chemotherapy. Traditionally, patients are treated with a combination of agents although recent data from relapse patients have suggested that low risk patients might benefit from single agent vinblastine and, going forward, the addition of ALK inhibitors to the therapeutic regimen may have beneficial consequences. There are also a plethora of other drugs that might be advantageous to patients with ALCL and many of these have been identified through laboratory research although the decision as to which drugs to implement in trials will not be trivial.

Keywords: ALK inhibitors; T cell lymphoma; anaplastic large cell lymphoma; anaplastic lymphoma kinase.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources